These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33325679)

  • 1. Specifically Eliminating Tumor-Associated Macrophages with an Extra- and Intracellular Stepwise-Responsive Nanocarrier for Inhibiting Metastasis.
    Guo N; Zhou Y; Wang T; Lin M; Chen J; Zhang Z; Zhong X; Lu Y; Yang Q; Xu D; Gao J; Han M
    ACS Appl Mater Interfaces; 2020 Dec; 12(52):57798-57809. PubMed ID: 33325679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocarriers responsive to a hypoxia gradient facilitate enhanced tumor penetration and improved anti-tumor efficacy.
    Zhen J; Tian S; Liu Q; Zheng C; Zhang Z; Ding Y; An Y; Liu Y; Shi L
    Biomater Sci; 2019 Jul; 7(7):2986-2995. PubMed ID: 31106796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
    Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
    Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species-responsive amino acid-based polymeric nanovehicles for tumor-selective anticancer drug delivery.
    Yuan Y; Zhao L; Shen C; He Y; Yang F; Zhang G; Jia M; Zeng R; Li C; Qiao R
    Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110159. PubMed ID: 31753404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH/redox dual-responsive amphiphilic zwitterionic polymers with a precisely controlled structure as anti-cancer drug carriers.
    Wu Z; Gan Z; Chen B; Chen F; Cao J; Luo X
    Biomater Sci; 2019 Aug; 7(8):3190-3203. PubMed ID: 31145392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precise Polymerization of a Highly Tumor Microenvironment-Responsive Nanoplatform for Strongly Enhanced Intracellular Drug Release.
    Wang Y; Zhang L; Zhang X; Wei X; Tang Z; Zhou S
    ACS Appl Mater Interfaces; 2016 Mar; 8(9):5833-46. PubMed ID: 26889562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional PLGA Nanobubbles as Theranostic Agents: Combining Doxorubicin and P-gp siRNA Co-Delivery Into Human Breast Cancer Cells and Ultrasound Cellular Imaging.
    Yang H; Deng L; Li T; Shen X; Yan J; Zuo L; Wu C; Liu Y
    J Biomed Nanotechnol; 2015 Dec; 11(12):2124-36. PubMed ID: 26510307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicin.
    Chen WL; Li F; Tang Y; Yang SD; Li JZ; Yuan ZQ; Liu Y; Zhou XF; Liu C; Zhang XN
    Int J Nanomedicine; 2017; 12():4241-4256. PubMed ID: 28652730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational Design of Nanoparticles to Overcome Poor Tumor Penetration and Hypoxia-Induced Chemotherapy Resistance: Combination of Optimizing Size and Self-Inducing High Level of Reactive Oxygen Species.
    Deng L; Feng Z; Deng H; Jiang Y; Song K; Shi Y; Liu S; Zhang J; Bai S; Qin Z; Dong A
    ACS Appl Mater Interfaces; 2019 Sep; 11(35):31743-31754. PubMed ID: 31389686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted co-delivery of the aldose reductase inhibitor epalrestat and chemotherapeutic doxorubicin via a redox-sensitive prodrug approach promotes synergistic tumor suppression.
    Banala VT; Urandur S; Sharma S; Sharma M; Shukla RP; Marwaha D; Gautam S; Dwivedi M; Mishra PR
    Biomater Sci; 2019 Jun; 7(7):2889-2906. PubMed ID: 31086900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selectively targeting tumor-associated macrophages and tumor cells with polymeric micelles for enhanced cancer chemo-immunotherapy.
    Wei X; Liu L; Li X; Wang Y; Guo X; Zhao J; Zhou S
    J Control Release; 2019 Nov; 313():42-53. PubMed ID: 31629039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering Endogenous Tumor-Associated Macrophage-Targeted Biomimetic Nano-RBC to Reprogram Tumor Immunosuppressive Microenvironment for Enhanced Chemo-Immunotherapy.
    Wang Y; Yu J; Luo Z; Shi Q; Liu G; Wu F; Wang Z; Huang Y; Zhou D
    Adv Mater; 2021 Oct; 33(39):e2103497. PubMed ID: 34387375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier.
    Sun JJ; Chen YC; Huang YX; Zhao WC; Liu YH; Venkataramanan R; Lu BF; Li S
    Acta Pharmacol Sin; 2017 Jun; 38(6):823-834. PubMed ID: 28504251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced anticancer activity and circumvention of resistance mechanisms by novel polymeric/ phospholipidic nanocarriers of doxorubicin.
    Senkiv Y; Riabtseva A; Heffeter P; Boiko N; Kowol CR; Jungwith U; Shlyakhtina Y; Garasevych SG; Mitina N; Berger W; Zaichenko A; Stoika R
    J Biomed Nanotechnol; 2014 Jul; 10(7):1369-81. PubMed ID: 24804557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer Platelet-Mimicking Nanovehicles.
    Hu Q; Sun W; Qian C; Wang C; Bomba HN; Gu Z
    Adv Mater; 2015 Nov; 27(44):7043-50. PubMed ID: 26416431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid modified doxorubicin loaded Fe
    Gong T; Dong Z; Fu Y; Gong T; Deng L; Zhang Z
    J Mater Chem B; 2019 Oct; 7(38):5861-5872. PubMed ID: 31512706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facile synthesis of organosilica-capped mesoporous silica nanocarriers with selective redox-triggered drug release properties for safe tumor chemotherapy.
    Shen L; Pan S; Niu D; He J; Jia X; Hao J; Gu J; Zhao W; Li P; Li Y
    Biomater Sci; 2019 Apr; 7(5):1825-1832. PubMed ID: 30892297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design of multimodal therapeutic nanosystems for effective inhibition of tumor growth and metastasis.
    Wang F; Huang Q; Wang Y; Zhang W; Lin R; Yu Y; Shen Y; Cui H; Guo S
    Acta Biomater; 2018 Sep; 77():240-254. PubMed ID: 30012354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP responsive DNA nanogels grown on biocompatible branches for anticancer drug delivery.
    Zhao M; Zhang Y; Yuan S; Xu X; Wu Z; Wu Z; Qi X
    Soft Matter; 2019 May; 15(18):3655-3658. PubMed ID: 31012474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo.
    Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN
    Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.